Cargando…
SH3-domain mutations selectively disrupt Csk homodimerization or PTPN22 binding
The kinase Csk is the primary negative regulator of the Src-family kinases (SFKs, e.g., Lck, Fyn, Lyn, Hck, Fgr, Blk, Yes), phosphorylating a tyrosine on the SFK C-terminal tail that mediates autoinhibition. Csk also binds phosphatases, including PTPN12 (PTP-PEST) and immune-cell PTPN22 (LYP/Pep), w...
Autores principales: | Brian, Ben F., Sjaastad, Frances V., Freedman, Tanya S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989918/ https://www.ncbi.nlm.nih.gov/pubmed/35393453 http://dx.doi.org/10.1038/s41598-022-09589-9 |
Ejemplares similares
-
TRAF3 enhances TCR signaling by regulating the inhibitors Csk and PTPN22
por: Wallis, Alicia M., et al.
Publicado: (2017) -
The Tyrosine Kinase Csk Dimerizes through Its SH3 Domain
por: Levinson, Nicholas M., et al.
Publicado: (2009) -
Theoretical Insights Reveal Novel Motions in Csk’s SH3 Domain That Control Kinase Activation
por: Barkho, Sulyman, et al.
Publicado: (2015) -
Role of PTPN22 and CSK gene polymorphisms as predictors of susceptibility and clinical heterogeneity in patients with Henoch-Schönlein purpura (IgA vasculitis)
por: López-Mejías, Raquel, et al.
Publicado: (2015) -
Correction: Theoretical Insights Reveal Novel Motions in Csk’s SH3 Domain That Control Kinase Activation
por: Barkho, Sulyman, et al.
Publicado: (2015)